Table 1 Results of sequencing sgRNA PCR products from talazoparib-resistant mouse ES cell clones isolated from the CRISPR screen described in Fig. 1a

From: Genome-wide and high-density CRISPR-Cas9 screens identify point mutations in PARP1 causing PARP inhibitor resistance

Clone

Likely cause of resistance

Clonal with

sgRNAs identified

BR1

Parp1

7

Parp1 (#1), Tmed5

BR2

Parp1

Parp1 (#1)

BR3

 

Gpd2

BR4

 

Tbx20, Gpr89, Pde4d, Arhgap12

BR5

 

21

Trp53, Csmd1

BR6

Parp1

Parp1 (#2), Apol6

BR7

Parp1

12,1

Parp1 (#1), Abca14, Dtnb, Tmed5

BR8

Parp1 #2

Parp1 (#2), Lemd1, Slmo1

BR9

Parp1 #2

Parp1 (#2)

BR10

Parp1

Parp1 (#1), Spock1, P2ry6, AW209491

BR11

Tdg

14

Tdg, Gm5597

BR12

Parp1 (by clonality)

7

Abca14, Dtnb

BR13

Parp1

Parp1 (#1), Nwd1, Scn10a

BR14

Tdg

11

Tdg, Gm5597, Tmed5

BR15

 

ND

BR16

 

Defb25

BR17

 

ND

BR18

 

Traf3ip1, Hkdc1, Gm4876

BR19

 

Dnajb11, Scaf8, Acbd3, Msh2

BR20

 

ND

BR21

 

5

Trp53, Csmd3, Chst15

BR22

 

Cyp2r1, Tmem69

BR23

 

ND

BR24

Tdg

Tdg

  1. Where clonality can be inferred from the combination of different guides observed, this is shown in column three
  2. ND not determined (failure of PCR and/or sequencing)